Delivery Order SPE2DB22D9353-SPE2DB25FX2BY
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $27,961.92 to DMS Pharmaceutical Group Inc. for the supply of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used for emergency reversal of anticoagulation. The award, effective August 25, 2025 with completion targeted for September 16, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency (DLA) for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used to reverse anticoagulation. The firm fixed-price delivery order has a ceiling value of $19,845.12 with an ultimate completion date of August 15, 2025. This award was issued without a set-aside designation,...
- The Defense Logistics Agency awarded a $27,961.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 19, 2025, for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used for treating bleeding associated with warfarin or novel anticoagulant overdose. This delivery order, with an ultimate completion date of September 10, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $13,546.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 500-unit vials of Kcentra. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, employs firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,213.76 by the Defense Logistics Agency on August 26, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a prothrombin complex concentrate used to reverse warfarin anticoagulation. The delivery order carries an ultimate completion date of September 17, 2025, and was awarded without a set-aside...
- The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,477.76 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical treatment. This delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $93,282.40 by the Defense Logistics Agency (DLA) on August 28, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical settings. The delivery order carries an ultimate completion date of September 19, 2025, and was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,539.52 by the Defense Logistics Agency on August 18, 2025, for the supply of Kcentra 500 unit vials. The contract carries an ultimate completion date of September 9, 2025, and is not designated under any set-aside program. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $21,888.00 to DMS Pharmaceutical Group Inc. for the supply of Kcentra 500 unit vials. This delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a total value of $499,999,999 and extends through November 2026. The delivery will be...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $39,520 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used for rapid reversal of warfarin anticoagulation. This firm fixed-price delivery order, issued on August 12, 2025, with ultimate completion by September 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The product will be delivered to Park Ridge, Illinois, where the vendor maintains its operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as a critical supplier within the federal pharmaceutical supply chain for the Department of Defense. The company leverages its $500 million DLA IDC under the SPE2DB program to fulfill delivery orders for an extensive portfolio of pharmaceutical products supporting military health facilities nationwide. This award required no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace based on its established capabilities and pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.5k | 8/12/25 |